Evidence map›Paper›PMID 33969391›Full record

ArticleBrain : a journal of neurology2021

RFC1 expansions are a common cause of idiopathic sensory neuropathy.

Riccardo Currò, Alessandro Salvalaggio, Stefano Tozza, Chiara Gemelli, Natalia Dominik, Valentina Galassi Deforie, Francesca Magrinelli, Francesca Castellani, Elisa Vegezzi, Pietro Businaro and 31 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 130 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Observational
  5. Review
  6. Corticospinal conduction in RFC1-related disease: a transcranial magnetic stimulation study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors at 10 institutions in 2 countries.

Riccardo CurròDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Alessandro SalvalaggioDepartment of Neurosciences, ERN Neuromuscular Unit, University of Padova, Padova, Italy.ORCID 0000-0002-1273-7566
Stefano TozzaDepartment of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Chiara GemelliDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Natalia DominikDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Valentina Galassi DeforieDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Francesca MagrinelliDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0003-4706-6245
Francesca CastellaniDepartment of Neurosciences, ERN Neuromuscular Unit, University of Padova, Padova, Italy.
Elisa VegezziDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Pietro BusinaroDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0002-5990-4640
Ilaria CallegariDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Anna PichiecchioDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Giuseppe CosentinoDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Enrico AlfonsiIRCCS Mondino Foundation, Pavia, Italy.
Enrico MarchioniIRCCS Mondino Foundation, Pavia, Italy.
Silvia ColnaghiIRCCS Mondino Foundation, Pavia, Italy.
Simone GanaIRCCS Mondino Foundation, Pavia, Italy.
Enza Maria ValenteIRCCS Mondino Foundation, Pavia, Italy.ORCID 0000-0002-0600-6820
Cristina TassorelliDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Stephanie EfthymiouDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Stefano FacchiniDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Aisling CarrDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Matilde LauraDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Alexander M RossorDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Hadi ManjiDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Michael P LunnDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0003-3174-6027
Elena PegoraroDepartment of Neurosciences, ERN Neuromuscular Unit, University of Padova, Padova, Italy.
Lucio SantoroDepartment of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Marina GrandisDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Emilia BelloneDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Nicholas J BeauchampSheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, Western Bank, Sheffield, UK.
Marios HadjivassiliouAcademic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust and University of Sheffield, Sheffield, UK.
Diego KaskiDepartment of Brain Sciences, Neuro-otology Unit, Imperial College London, London, UK.
Adolfo M BronsteinDepartment of Brain Sciences, Neuro-otology Unit, Imperial College London, London, UK.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-2866-7777
Mary M ReillyDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Paola MandichDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Angelo SchenoneDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Fiore ManganelliDepartment of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Chiara BrianiDepartment of Neurosciences, ERN Neuromuscular Unit, University of Padova, Padova, Italy.
Andrea CorteseDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0002-2208-5311
National Hospital for Neurology and Neurosurgery · GBUniversity of Pavia · ITOspedale Policlinico San Martino · ITUniversity of Padua · ITUniversity of Naples Federico II · ITImperial College London · GBSheffield Children's NHS Foundation Trust · GBSheffield Teaching Hospitals NHS Foundation Trust · GBUniversity College London · GBUniversity of Verona · IT

Funding

Medical Research Council MR/T001712/1Wellcome Trust
6 · The paper itself

Abstract

After extensive evaluation, one-third of patients affected by polyneuropathy remain undiagnosed and are labelled as having chronic idiopathic axonal polyneuropathy, which refers to a sensory or sensory-motor, axonal, slowly progressive neuropathy of unknown origin. Since a sensory neuropathy/neuronopathy is identified in all patients with genetically confirmed RFC1 cerebellar ataxia, neuropathy, vestibular areflexia syndrome, we speculated that RFC1 expansions could underlie a fraction of idiopathic sensory neuropathies also diagnosed as chronic idiopathic axonal polyneuropathy. We retrospectively identified 225 patients diagnosed with chronic idiopathic axonal polyneuropathy (125 sensory neuropathy, 100 sensory-motor neuropathy) from our general neuropathy clinics in Italy and the UK. All patients underwent full neurological evaluation and a blood sample was collected for RFC1 testing. Biallelic RFC1 expansions were identified in 43 patients (34%) with sensory neuropathy and in none with sensory-motor neuropathy. Forty-two per cent of RFC1-positive patients had isolated sensory neuropathy or sensory neuropathy with chronic cough, while vestibular and/or cerebellar involvement, often subclinical, were identified at examination in 58%. Although the sensory ganglia are the primary pathological target of the disease, the sensory impairment was typically worse distally and symmetric, while gait and limb ataxia were absent in two-thirds of the cases. Sensory amplitudes were either globally absent (26%) or reduced in a length-dependent (30%) or non-length dependent pattern (44%). A quarter of RFC1-positive patients had previously received an alternative diagnosis, including Sjögren's syndrome, sensory chronic inflammatory demyelinating polyneuropathy and paraneoplastic neuropathy, while three cases had been treated with immune therapies.

Indexed as

AdultAgedDNA Repeat ExpansionFemaleHumansMaleMiddle AgedPolyneuropathiesReplication Protein CReplication Protein CRFC1 protein, humanCANVASchronic idiopathic axonal polyneuropathyRFC1sensory neuropathy

Identifiers

PMID33969391
PMCPMC8262986
OpenAlexW3161243928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.